Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Alexander Novotny is a leading figure in surgical oncology, whose work has fundamentally advanced the treatment of gastric cancer. His research is singularly focused on evaluating and refining minimally invasive surgical techniques, specifically comparing robotic, laparoscopic, and traditional open gastrectomy. Dr. Novotny’s major contribution lies in his rigorous, evidence-based approach to this comparison. Through his landmark 2017 propensity score-matched study (100 citations), he provided critical data on surgical, clinical, and oncological outcomes across all three modalities, helping to define the true benefits and limitations of each. He is the driving force behind the IMIGASTRIC study group, a multi-institutional, international collaborative that he initiated to generate the high-quality, prospective evidence needed to guide clinical practice. By systematically highlighting the limits of existing literature in his 2015 review (36 citations) and designing robust protocols like IMIGASTRIC I and II, Dr. Novotny has not only shaped current surgical decision-making but has also laid the groundwork for the future of minimally invasive gastric cancer surgery.